Antioxidant therapy attenuates aminoglycoside-induced hearing loss

Annals of the New York Academy of Sciences

Volumn 884, Issue , 1999, Pages 125-130

  Schacht, Jochen ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE; ANTIOXIDANT; FREE RADICAL; IRON CHELATING AGENT;

ANTIBACTERIAL ACTIVITY; CONFERENCE PAPER; GUINEA PIG; HEARING LOSS; HUMAN; IRON CHELATION; NONHUMAN; OTOTOXICITY; OXIDATION REDUCTION REACTION; VESTIBULAR DISORDER;

EID: 0032779858     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Conference Paper

References (30)

1. 1. Jacono, A. A., B. H. Hu, R. Kopke, D. Henderson, T.R. Van De Water & H. Steinman. 1998. Changes in cochlear antioxidant enzyme activity after sound conditioning and noise exposure in the chinchilla. Hear. Res. 117: 31-38.
2. 2. Altschuler, R. A., J. M. Miller, Y. Raphael & J. Schacht. 1999. Strategies for protection of the inner ear from noise-induced hearing loss. In Cochlear Pharmacology and Noise Trauma, D. Prasher and B. Canlon, Eds.: 98-107. NRN Publications. London.
3. 3. Rybak, L. P., K. Husain, L. Evenson, C. Morris, C. Whitworth & S. M. Somani. 1997. Protection by 4-methylthiobenzoic acid against cisplatin-induced ototoxicity: antioxidant system. Pharmacol. Toxicol. 81: 173-179.
4. 4. Schatz, A., E. Bugie & S. A. Waksman. 1944. Streptomycin, a substance exhibiting antibiotic activity against gram-positive and gram-negative bacteria. Proc. Soc. Exp. Biol. Med. 55: 66-69.
5. 5. Hinshaw, H. C. & W. H. Feldman. 1945. Streptomycin in treatment of clinical tuberculosis: a preliminary report. Proc. Mayo Clinic 20: 313-318.
6. 6. Hawkins, J. E., Jr. 1976. Drug ototoxicity. In Handbook of Sensory Physiology, Vol. 5, Part 3, W. D. Keidel and W.D. Neff, Eds.: 707-748. Springer-Verlag. Berlin.
7. 7. Fee, W. E. 1980. Aminoglycoside ototoxicity in the human. Laryngoscope 40: 1-19.
8. 8. Lerner, S. A., B. A. Schmitt, R. Seligsoh & G. J. Matz. 1986. Comparative-study of ototoxicity and nephrotoxicity in patients randomly assigned to treatment with amikacin or gentamicin. Amer. J. Med. 80: 98-104.
9. 9. Mulherin, D., J. Fahy, W. Grant, M. Keogan, B. Kavanagh & M. Fitzgerald. 1991. Aminoglycoside induced ototoxicity inpatients with cystic fibrosis. Irish J. Med. Sci. 160: 173-175.
10. 10. Fu, D. M. 1985. Survey of 1583 deaf mutes. Qinghai Med. J. 1: 22-23.
11. 11. Lu, Y. F. 1987. Cause of 611 deaf mutes in schools for deaf children in Shanghai. Shanghai Med. J. 10: 159.
12. 12. Prazma, J., H. G. Garrison, S. K. Williford, S. D. Ferguson, J. Fischer, A. Drake & L. E. Klingler. 1983 Alteration of aminoglycoside antibiotic ototoxicity, effect of semi-starvation. Ann. Otol. Rhinol. & Laryngol. 92: 178-182.
13. 13. Hoffman, D. W., K. L. Jones-King, C. A. Whitworth & L. P. Rybak. 1988. Potentiation of ototoxicity by glutathione depletion. Ann. Otol. Rhinol. & Laryngol. 97: 36-41.
14. 14. Lautermann, J., J. McLaren & J. Schacht. 1995. Glutathione protection against gentamicin ototoxicity depends on nutritional status. Hear. Res. 86: 15-24.
15. 15. Walker, P. D. & S. V. Shah. 1987. Gentamicin enhanced production of hydrogen peroxide by renal cortical mitochondria. Amer. J. Physiol. 253: C495-C499.
16. 16. Yang, C. L., X. H. Du & Y. X. Han. 1995. Renal cortical mitochondria are the source of oxygen free radicals enhanced by gentamicin. Renol. Failure 17: 21-26.
17. 17. Clerici, W. J., K. Hensley, D. L. Dimartino & D. A. Butterfield. 1996. Direct detection of ototoxicant-induced reactive oxygen species generation in cochlear expiants. Hear. Res. 98: 116-124.
18. 18. Hirose, K., D. N. Hockenberry & E. W. Rubel. 1997. Reactive oxygen species in chick hair cells after gentamicin exposure in vitro. Hear. Res. 104: 1-14.
19. 19. Huang, M. Y. & J. Schacht. 1990. Formation of a cytotoxic metabolite from gentamicin by liver. Biochem. Pharmacol. 40: R11-R14.
20. 20. Garetz, S. L., D. J. Rhee & J. Schacht. 1994. Sulfhydryl compounds and antioxidants inhibit cytotoxicity to outer hair cells of a gentamicin metabolite in vitro. Hear. Res. 77: 75-80.
21. 21. Priuska, E. M., K. Clark, V. Pecoraro & J. Schacht. 1998. NMR spectra of iron-gentamicin complexes and the implications for aminoglycoside toxicity. Inorg. Chim. Acta 273: 85-91.
22. 22. Priuska, E. M. & J. Schacht. 1995. Formation of free radicals by gentamicin and iron and evidence for an iron/gentamicin complex. Biochem. Pharmacol. 50: 1749-1752.
23. 23. Sha, S.-H. & J. Schacht. 1999. Formation of reactive oxygen species following bioactivation of gentamicin. Free Rad. Biol. Med. 26: 341-347.
24. 24. Song, B.-B. & J. Schacht. 1996. Variable efficacy of radical scavengers and iron chelators to attenuate gentamicin ototoxicity in guinea pig in vivo. Hear. Res. 94: 87-93.
25. 25. Song, B.-B., D. J. Anderson & J. Schacht. 1997. Protection from gentamicin ototoxicity by iron chelators in guinea pig in vivo. J. Pharmacol. Exp. Ther. 282: 369-377.
26. 26. Song, B.-B., S.-H. Sha & J. Schacht. 1998. Iron chelators protect from aminoglycoside-induced cochleo-and vestibulotoxicity in guinea pig. Free Radical Biol. Med. 25: 189-195.
27. 27. Hershko, C. 1992. Iron chelators in medicine. Mol. Aspects Med. 13: 113-165.
28. 28. Kanno, H., S. Yamanobe & L.P. Rybak. 1995. The ototoxicity of deferoxamine mesylate. Amer. J. Otolaryngol. 16: 148-152.
29. 29. Peterson, C. M., J.H. Graziano, R. W. Grady, R. L. Jones, A. Markenson, U. Lavi, V. Canale, G. F. Gray, A. Cerami & D. R. Miller. 1979. Chelation therapy in β-thalassemia major: a one-year double blind study of 2,3-dihydroxybenzoic acid. Exp. Hematol. 7: 74-80.
30. 30. Sha, S. H. & J. Schacht. 1999. Salicylate attenuates gentamicin-induced ototoxicity. Lab. Invest. 79: 807-813.